On September 9, UnitedHealth declined 3.18% in regular trading, trading at $386.72/share, with turnover of $342 million. The sell-off was triggered by news that UnitedHealth sold an equity stake in some of its Florida-based Optum Health operations to private equity firm TPG.

The transaction covers UnitedHealth's WellMed clinic network, which primarily provides care to older adults. UnitedHealth has been restructuring Optum Health after a sharp profit decline last year, when higher medical costs and changes in federal payments pushed the division's margins into negative territory. Management stated the partnership would allow the Florida business to invest and expand faster, with approximately 15 new clinics opening per year, at a pace exceeding what UnitedHealth could achieve independently while pursuing its broader group transformation.

Market reaction to the asset sale leaned negative, reflecting investor concerns over the pace of Optum Health's profitability recovery and the group's overall restructuring trajectory. Notably, UnitedHealth had delivered a strong Q2 earnings beat in July, with adjusted EPS of $6.38 far exceeding analyst expectations, prompting multiple investment banks to raise their target prices above $470. The managed health care sector traded broadly lower, with Centene down 2.52%, Molina Healthcare down 1.23%, Humana down 1.21%, HealthEquity down 1.0%, and Elevance Health down 0.98%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)